ElevenLabs completed a $300 million employee tender offer that increased its reported valuation to $22 billion
Funding ● Confirmed 88% confidence first seen
ElevenLabs closed a $300 million employee tender offer in a secondary sale, resetting its share price and lifting its reported valuation to $22 billion. The coverage describes the tender as providing employees periodic liquidity and as following earlier funding rounds while the company continues scaling its voice and chat agent business and releasing text-to-speech models.
Decision brief
- What changed
- ElevenLabs completed a $300 million employee tender offer in a secondary sale, and coverage reports the transaction reset the company’s valuation to $22 billion. The tender offer gave employees liquidity without describing a new primary capital raise.
- Why it matters
- For leadership, this is a pricing and talent-retention signal: the company’s reported valuation doubled from its prior $11 billion level within months, while creating a mechanism for employees to realize value from equity. It also suggests ElevenLabs is using secondary liquidity to support scaling of its voice, chat agent, and text-to-speech product lines without the coverage indicating dilution from a new fundraising round.
- Evidence
- All three cited outlets — Trending Topics EU, Tech.eu, and Sifted — consistently report that ElevenLabs completed a $300 million employee tender offer and that the transaction set or reflected a $22 billion valuation. The reports also align that the deal provided employee liquidity and occurred after the company’s earlier funding at an $11 billion valuation, though they do not provide primary transaction documents.
- What remains uncertain
- The coverage does not clarify who led or priced the tender, how broad employee participation was, what share class was sold, or whether the $22 billion figure reflects fully diluted valuation terms comparable to prior rounds. It also does not verify whether regular employee liquidity will continue on a fixed cadence or how much this secondary pricing reflects durable operating performance versus investor demand.
- Monitor next
- Watch for any official company filing or announcement detailing tender participants, valuation methodology, and whether ElevenLabs follows this secondary sale with a primary fundraise or expanded product commercialization metrics.
Analytical support, not advice — assumptions and open questions stated above.